Endothelial-Monocyte Activating Polypeptide (EMAP) II is a unique, leaderless, single chain polypeptide protein first identified from murine fibrosarcoma. In its precursor form, it is 34-kDa molecule and is processed by unknown mechanisms to a mature 21-kDa form. Mature EMAP II (mEMAP II) is an extracellular molecule that is known to activate endothelial cells, neutrophils and mononuclear phagocytes and appears to be a proinflammatory mediator with the capacity to prime tumor vasculature for a locally destructive process or be anti-angiogenic in its own capacity. We recently demonstrated that mEMAP II is a director of neovascularization in the developing lung as its expression is inversely correlated to periods of vascularization and introduction of recombinant mEMAP II in a murine allograft model of lung development profoundly disrupts alveolar-capillary growth. In contrast to extracellular mEMAP II, considerably less is known regarding the function of the intracellular proform (pEMAP II). Our preliminary data suggest that pEMAP II must have an important intracellular function prior to its secretion because: 1) its levels are tightly regulated in relationship to the cell cycle, 2) it undergoes nucleocytoplasmic partitioning, and 3) it is post-translationally modified. Accordingly, specific alms of this proposal are: 1) To determine the role of intracellular pEMAP II's subcompartmentalization and post-translational modification within the cell cycle; 2) To determine the mechanism that affects intracellular processing of pEMAP II; 3) To determine the mechanism by which EMAP II is secreted; and 4) To identify the extracellular determinants of the pEMAP II / mEMAP II balance in regulating lung growth. Thus, identifying factors that govern the intracellular processing of pEMAP II and ultimately affect its secretion are critical determinants of the biological role of EMAP II and will provide insight into the determinants by which a balance of pEMAP II / mEMAP II can affect lung development.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL060061-06A2
Application #
6774376
Study Section
Respiratory Physiology Study Section (RESP)
Program Officer
Berberich, Mary Anne
Project Start
1998-05-01
Project End
2008-03-30
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
6
Fiscal Year
2004
Total Cost
$370,990
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Surgery
Type
Schools of Medicine
DUNS #
617022384
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Legan, Susan K; Lee, Daniel D; Schwarz, Margaret A (2017) ?5?1 integrin mediates pulmonary epithelial cyst formation. Dev Dyn 246:475-484
Xu, Haiming; Malinin, Nikolay L; Awasthi, Niranjan et al. (2015) The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein. J Biol Chem 290:9753-66
Yuan, Chujun; Yan, Lin; Solanki, Pallavi et al. (2015) Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis. J Mol Cell Cardiol 79:224-31
Lal, Charitharth Vivek; Schwarz, Margaret A (2014) Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II). Birth Defects Res A Clin Mol Teratol 100:180-8
Bennett, Katherine M; Afanador, Maria D; Lal, Charitharth V et al. (2013) Ephrin-B2 reverse signaling increases ?5?1 integrin-mediated fibronectin deposition and reduces distal lung compliance. Am J Respir Cell Mol Biol 49:680-7
Schwarz, Margaret A; Thornton, Janet; Xu, Haiming et al. (2012) Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II. PLoS One 7:e33101
Chen, Yao; Legan, Susan K; Mahan, Anne et al. (2012) Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation. Respir Res 13:1
Schwarz, Margaret A; Zheng, Haihua; Legan, Susan et al. (2011) Lung self-assembly is modulated by tissue surface tensions. Am J Respir Cell Mol Biol 44:682-91
Yu, Shibin; Poe, Bryan; Schwarz, Margaret et al. (2010) Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development. Dev Biol 347:92-108
Schwarz, Margaret A; Caldwell, Lauren; Cafasso, Danielle et al. (2009) Emerging pulmonary vasculature lacks fate specification. Am J Physiol Lung Cell Mol Physiol 296:L71-81